Clinical Trial Update: Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating SHR-1701 plus chemoradiotherapy for locally advanced rectal cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• SHR-1701

Snippet

Sponsor: Hong Qiu | Conditions: CRC (Colorectal Cancer) | Phase 2 | Status: RECRUITING